BioProduction Congress Dublin 2017
HPRA raises Brexit concerns: GMP mutual recognition & member state status
Irish regulators say it is still not clear how Brexit will affect companies that make drugs in the UK, raising issues like MA status and mutual inspection agreements between the EMA and US FDA as areas of concern.